Shijie Zhou
5PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 02, 2022
Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.Chunmei Hu, Jiangang Fan, Gang He
|May 16, 2021
NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop.Bowen Hu, Shijie Zhou, Xuefeng Hu
|Apr 20, 2020
RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.Zhao Xiang, Shijie Zhou, Shuang Liang
|Nov 20, 2019
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.Qinsheng Hu, Shijie Zhou, Xuefeng Hu
|Nov 01, 2017
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.Shijie Zhou, Ping Wang, Xiaolan Su
Pageof 1
